Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.613,30
-0,42%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Pfizer Inc (PFE) Pfizer Inc (PFE) Notizie

PFE

Pfizer (PFE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:PFE
DataOraFonteTitoloSimboloCompagnia
20/11/202412:45Business WirePfizer Announces New Chief Scientific Officer and President, Research & DevelopmentNYSE:PFEPfizer Inc
20/11/202410:00Business WireEuropean Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without InhibitorsNYSE:PFEPfizer Inc
18/11/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
14/11/202416:00Business WirePfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
29/10/202414:09IH Market NewsFutures Pointing To Modestly Lower Open On Wall StreetNYSE:PFEPfizer Inc
29/10/202413:06Edgar (US Regulatory)Form 8-K - Current reportNYSE:PFEPfizer Inc
29/10/202411:45Business WirePfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 GuidanceNYSE:PFEPfizer Inc
29/10/202410:41IH Market NewsUS Futures Rise as Investors Await Major Earnings; Oil Prices Rebound with US Reserve Refill PlanNYSE:PFEPfizer Inc
28/10/202414:09IH Market NewsSteep Drop By Oil Prices May Lead To Initial Strength On Wall StreetNYSE:PFEPfizer Inc
23/10/202422:45Business WireAdvisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and OlderNYSE:PFEPfizer Inc
22/10/202422:45Business WireU.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for DiseaseNYSE:PFEPfizer Inc
15/10/202423:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:PFEPfizer Inc
15/10/202412:45Business WireTim Buckley Elected to Pfizer’s Board of DirectorsNYSE:PFEPfizer Inc
14/10/202412:11IH Market NewsTSMC To Exceed Profits, Plans European Factories; Boeing Cuts 17,000 Jobs; Berkshire Boosts Sirius XM StakeNYSE:PFEPfizer Inc
11/10/202419:23Business WireU.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without InhibitorsNYSE:PFEPfizer Inc
11/10/202412:31IH Market NewsBP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and MoreNYSE:PFEPfizer Inc
10/10/202412:51Business WirePfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 TrialNYSE:PFEPfizer Inc
10/10/202412:45IH Market NewsTesla’s Robotaxi Day; GSK Settles 93% of Zantac Lawsuits; 10x Genomics Stock Drops on Revenue ForecastNYSE:PFEPfizer Inc
09/10/202422:30Business WirePfizer Declares Fourth-Quarter 2024 DividendNYSE:PFEPfizer Inc
09/10/202412:15IH Market NewsGoogle Could Face Forced Spinoff; Rio Tinto Buys Arcadium for $6.7B; Boeing Suspends Union TalksNYSE:PFEPfizer Inc
08/10/202422:45Business WirePfizer to Showcase Scientific Advancements in Respiratory and Other Infectious Diseases at IDWeek 2024NYSE:PFEPfizer Inc
07/10/202422:57IH Market NewsStocks Fall On Geopolitical Tensions; Major Averages Close Notably LowerNYSE:PFEPfizer Inc
07/10/202411:49IH Market NewsStarboard Acquires $1 Billion Stake in Pfizer; Rio Tinto Pursues Acquisition of Arcadium Lithium, and MoreNYSE:PFEPfizer Inc
04/10/202400:59Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NYSE:PFEPfizer Inc
02/10/202415:00InvestorsHub NewsWireTransforming Alzheimer's Treatment: Innovative Combinations to Boost CognitionNYSE:PFEPfizer Inc
25/09/202423:00Business WirePfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide MarketsNYSE:PFEPfizer Inc
20/09/202414:11Business WirePfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European UnionNYSE:PFEPfizer Inc
17/09/202423:01AllPennyStocks.comTargeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer HopeNYSE:PFEPfizer Inc
17/09/202416:00Business WirePfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with AnalystsNYSE:PFEPfizer Inc
14/09/202414:45Business WirePfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer CachexiaNYSE:PFEPfizer Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:PFE

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network